The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
. Effects of serelaxin in patients with acute heart failure
Open accessAbstract
BACKGROUND: Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure. METHODS: In this multicenter, double-blind, placebo-controlled, event-driven trial, we enrolled patients who were hospitalized for acute heart failure and had dyspnea, vascular congestion on chest radiography, increased plasma concentrations of natriuretic peptides, mild-to-moderate renal insufficiency, and a systolic blood pressure of at least 125 mm Hg, and we randomly assigned them within 16 hours after presentation to receive either a 48-hour intravenous infusion of serelaxin (30 μg per kilogram of body weight per day) or placebo, in addition to standard care. The two primary end points were death from cardiovascular causes at 180 days and worsening heart failure at 5 days. RESULTS: A total of 6545 patients were included in the intention-to-treat analysis. At day 180, death from cardiovascular causes had occurred in 285 of the 3274 patients (8.7%) in the serelaxin group and in 290 of the 3271 patients (8.9%) in the placebo group (hazard ratio, 0.98; 95% confidence interval [CI], 0.83 to 1.15; P = 0.77). At day 5, worsening heart failure had occurred in 227 patients (6.9%) in the serelaxin group and in 252 (7.7%) in the placebo group (hazard ratio, 0.89; 95% CI, 0.75 to 1.07; P = 0.19). There were no significant differences between the groups in the incidence of death from any cause at 180 days, the incidence of death from cardiovascular causes or rehospitalization for heart failure or renal failure at 180 days, or the length of the index hospital stay. The incidence of adverse events was similar in the two groups. CONCLUSIONS: In this trial involving patients who were hospitalized for acute heart failure, an infusion of serelaxin did not result in a lower incidence of death from cardiovascular causes at 180 days or worsening heart failure at 5 days than placebo. (Funded by Novartis Pharma; RELAX-AHF-2 ClinicalTrials.gov number, NCT01870778.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the RELAX -AHF phase-III clinical trial failed in achieving the primary end -points of lowering the 6-month total and cardiovascular adverse events, 3”
From Revivifying research on relaxin receptor-targeted therapy for cardiovascular diseases (2025) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
O'Connor, C. M., Starling, R. C., Hernandez, A. F., Armstrong, P. W., Dickstein, K., Hasselblad, V., Heizer, G., Michel Komajda, N., Massie, B. M., McMurray, J. J. V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100171 · Cited by 1,249
Self-citationTeerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G. S., Greenberg, B., Ponikowski, P. P., Unemori, E., Voors, A. A., Adams, K. F., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61855-8 · Cited by 926
Self-citationRehospitalization for Heart Failure
Gheorghiade, M., Vaduganathan, M., Fonarow, G. C., & Bonow, R. O. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.038 · Cited by 769
Solomon, S. D., Dobson, J., Pocock, S., Skali, H., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Young, J. B., Michelson, E. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.696906 · Cited by 681
Relaxin family peptides and their receptors
Bathgate, R. A. D., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., & Summers, R. J. (2013) · Physiological Reviews · doi:10.1152/physrev.00001.2012 · Cited by 534
Packer, M., Colucci, W. S., Fisher, L. D., Massie, B. M., Teerlink, J. R., Young, J. B., Padley, R. J., Thakkar, R. B., Delgado‐Herrera, L., Salon, J. E., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2012.12.004 · Cited by 443
Self-citationHarjola, V., Müllens, W., Banaszewski, M., Bauersachs, J. K., Rocca, H. B., Chioncel, O., Collins, S. P., Doehner, W., Filippatos, G. S., Flammer, A. J., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.872 · Cited by 435
Self-citationMetra, M., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G. S., Greenberg, B., Ponikowski, P. P., Unemori, E., Voors, A. A., Adams, K. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.005 · Cited by 427
Self-citationTeerlink, J. R., Metra, M., Felker, G. M., Ponikowski, P. P., Voors, A. A., Davison, B. A., Marmor, A. T., Katz, A., Grzybowski, J., Unemori, E., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60622-x · Cited by 422
Self-citationA graphical approach to sequentially rejective multiple test procedures
Bretz, F., Maurer, W., Brannath, W., & Posch, M. (2009) · Statistics in Medicine · doi:10.1002/sim.3495 · Cited by 420
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–283 of 283
Revivifying research on relaxin receptor-targeted therapy for cardiovascular diseases
Du, X.-J. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf057 · Cited by 1
Single‐Shot Solid‐Phase Synthesis of Full‐Length H2 Relaxin Disulfide Surrogates
Zhao, R. J., Shi, P., Cui, J., Shi, C., Wei, X., Luo, J., Xia, Z., Shi, W., Zhou, Y., Tang, J., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202216365 · Cited by 1
Long-acting relaxin analogues: a novel tool in cardiology
Wołowiec, Ł., Jaśniak, A., Osiak, J., Czaplińska, D., Szymczak, A., Pęcherz, J. A., & Grześk, G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1626469 · Cited by 1
Impact of Mild and Moderate Aortic Stenosis in Acute Heart Failure: Insights From RELAX-AHF-2
Venema, C. S., Metra, M., Staal, L., Beldhuis, I. E., Cotter, G., Davison, B. A., Felker, G. M., FILIPPATOS, G., Greenberg, B., Pang, P. S., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.07.017 · Cited by 1
Self-citationSingle cell transcriptomic landscape of adult and pediatric non-ischemic cardiomyopathy
Tadros, H. J. J., Turaga, D., Hope, K. D., Spinner, J. A., Adachi, I., Li, X., & Martin, J. F. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.12.002 · Cited by 1
Ryberg, E., Bergström, F., Sten, S., Olsson, J., Lal, M., Connolly, K., Matsson, E. M., Åstrand, M., Althage, M., Hartman, R. J. G., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201674 · Cited by 1
Istaroxime – update of data in early cardiogenic shock and decompensated heart failure
Florek, K., Zimoch, W., & Biegus, J. (2026) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2026.2618978 · Cited by 1
Belenichev, I. F., Popazova, O., Goncharov, O., Bukhtiyarova, N. V., Ryzhenko, V. P., Semenov, D., Oliynyk, S., Petakh, P., & Kamyshnyi, O. (2026) · Biomedicines · doi:10.3390/biomedicines14051018 · Cited by 3
Development of a long‐acting relaxin for the treatment of pulmonary hypertension
Diener, J., Soni, H., Booe, J., Darce, J., MacBain, Z., Thulasiraman, S., Knihtila, R., Bencsics, C. E., Ghosh, S., Denney, W., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70498 · Cited by 2
Biologics for cardiovascular diseases: from bench to bedside
Sun, X., Wang, X., Jia, R., Tang, J., Zeng, X. Y., Zhao, F., Zeng, F., Huang, N., Li, J., & Cui, K. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02673-w · Cited by 2
Liang, H., Wang, Y., Xin, Y., Li, Y., Zhang, C., & Yang, Y. (2026) · BMC Emergency Medicine · doi:10.1186/s12873-026-01628-2 · Cited by 1
Cho, I., Oh, J., Kim, I., Chung, H., Lee, J., Kim, H. M., Byun, Y. S., Yoo, B., Choi, E., Chung, W., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.765081 · Cited by 1
Use of vasodilators in patients with acute heart failure: contra
Mueller, C. E., & Kozhuharov, N. (2022) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuac127 · Cited by 1
Self-citationKobalava, Z. D., & Nazarov, I. S. (2023) · Kardiologiia · doi:10.18087/cardio.2023.3.n2418 · Cited by 1
Hou, G., Alissa, M., Alsuwat, M. A., Alarjany, H. M. A., Alzahrani, K. J., Althobaiti, F. M., Mujalli, H. M., Alotaiby, M. M., Al-Doaiss, A. A., & Anthony, S. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102627 · Cited by 1
Inciardi, R. M., Staal, L., Davison, B. A., Lombardi, C., Postmus, D., Felker, G. M., Filippatos, G. S., Greenberg, B., Pang, P. S., Ponikowski, P. P., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3451 · Cited by 1
Self-citationMallart, S., Ingenito, R., Magotti, P., Bresciani, A., Marco, A. D., Esposito, S., Monteagudo, E. S., Caretti, F., Orsatti, L., Santoprete, A., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03085 · Cited by 1
The year in cardiology: heart failure The year in cardiology 2019
Cleland, J. G. F., Lyon, A. R., McDonagh, T. A., & McMurray, J. J. V. (2020) · Cardiologia Croatica · doi:10.15836/ccar2020.167 · Cited by 1
Self-citationDiagnosis dan Tatalaksana Terkini Gagal Jantung Akut
Saroinsong, L., Jim, E. L., & Rampengan, S. H. (2021) · e-CliniC · doi:10.35790/ecl.v9i1.31857 · Cited by 1
Kang, H. Y., Narasamuloo, K. R., Silveraju, A. R., Said, M. R. M., Leong, C. W., Ibrahim, A. H., & Krishinan, S. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.10.104 · Cited by 1
Bullying as a Disability in Public Elementary and Secondary EducationPreprint
Abrams, D. E. (2012) · SSRN Electronic Journal · Cited by 1
Deswal, A. M., & Kumar, S. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.07.001 · Cited by 1
Bhatty, A., Wilkinson, C., Aktaa, S., Batra, G., Beska, B., Khaing, P. H., Wahab, A., Raveendera, K., Taha, A., Nadarajah, R., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5116096 · Cited by 1
Serelaxin treatment does not reduce incidence of death in patients with AHF
Huynh, K. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0264-4
Cardiology update – Third quarter
Yadav, S. (2019) · Journal of the Practice of Cardiovascular Sciences · doi:10.4103/jpcs.jpcs_60_19
Selección de lo mejor del año 2019 en insuficiencia cardiaca
García‐Pinilla, J. M., González‐Costello, J., Torres, M. F., González-Vílchez, F., Carmena, M. D. G., Mayoral, A. R., García-Garrido, L., & Segovia, J. (2019) · REC CardioClinics · doi:10.1016/j.rccl.2019.10.016
Patent Highlights April–May 2020
Mucke, H. A. (2020) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2020-0018
Selección de lo mejor del año 2020 en insuficiencia cardiaca
García‐Pinilla, J. M., Carmena, M. D. G., Farrero, M., Mayoral, A. R., & González‐Costello, J. (2021) · REC CardioClinics · doi:10.1016/j.rccl.2020.11.009
Papadimitriou, L., Hernandez, G. A., Lennep, B., Long, R. C., Butler, J., & Kalogeropoulos, A. P. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00905-6
Zhang, X., Zhou, K., Zhang, J., Chen, Y., Dai, H., Wan, S., Guan, Z., Hu, M., Kang, J., Liu, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-948336/v1
Electrolyte disturbances in heart failure
Beusekamp, J. C. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.196047233
Is worsening renal function relevant without clinical context?
Warraich, H. J., & Nohria, A. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2416
Short Course Digoxin in Acute Heart Failure
Nouira, S. (2022) · Open Access Journal of Biogeneric Science and Research · doi:10.46718/jbgsr.2022.11.000258
Kinugawa, K. (2020) · Springer eBooks · doi:10.1007/978-981-15-4843-7_1
Acute heart failure: early pharmacological therapy
Docherty, K. F., Dalzell, J. R., Petrie, M. C., & McMurray, J. J. V. (2021) · doi:10.1093/med/9780198849346.003.0047
Gardner, R. S., McDonagh, T. A., & Clark, A. L. (2022) · doi:10.1093/med/9780198766223.003.0069
Piper, S. E., & McDonagh, T. A. (2022) · doi:10.1093/med/9780198766223.003.0045
Relaxin family peptide receptors in GtoPdb v.2023.1
Agoulnik, A. I., Bathgate, R. A. D., Dschietzig, T. B., Gundlach, A. L., Halls, M. L., Smith, C. M., & Summers, R. J. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f60/2023.1
NITRIC OXIDE CAUSES NITROGLYCERIN TOLERANCE: NOVEL TREATMENTS TARGETING SUPEROXIDEPreprint
Kaesemeyer, W. (2023) · doi:10.22541/au.169154826.62190713/v1
Intensivtherapie bei akuter Herzinsuffizienz, kardiogenem Schock und Herzbeuteltamponade
Iken, S., Calineata, M., Reyher, C., & Zierer, A. F. (2023) · Springer Reference Medizin · doi:10.1007/978-3-642-54675-4_61-2
Prise en charge thérapeutique de l’insuffisance cardiaque aiguë et chronique
Deniau, B., & Gayat, É. (2023) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.10.005
Relaxin as a biological marker and therapeutic target in heart failure
Alieva, A. M., Reznik, E. V., Baykova, I. E., Teplova, N. V., Voronkova, K. V., Kovtyukh, I. V., Khadzhieva, N. K., Surskaya, E. V., Kotikova, I. A., & Nikitin, I. G. (2023) · Russian Medicine · doi:10.17816/medjrf397336
Jung, J., & Han, H. H. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4627115
Rice, B. J., Mbatidde, L., Oluleye, O. W., Onwuanyi, A., & Adedinsewo, D. A. (2023) · Journal of the National Medical Association · doi:10.1016/j.jnma.2023.11.004
Polyzogopoulou, E., Nikolaou, M., Parissis, J., & Mebazaa, A. (2023) · doi:10.1093/med/9780198891628.003.0046
Acute heart failure: pharmacological and non-pharmacological management
Fountoulaki, K., Parissis, J., Collins, S. P., Yılmaz, M. B., & Mebazaa, A. (2023) · doi:10.1093/med/9780198891628.003.0060
New Cimlanod Trial Provides Insights Into Mechanistic Effects of Vasodilators in Heart Failure
Collins, N. J., Ngo, D. T. M., & Sverdlov, A. L. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.3110
Pharmacology in Noninvasive Ventilation in Cardiac Pulmonary Edema
Öcal, S., & Sağlam, C. E. (2023) · Noninvasive ventilation. The essentials · doi:10.1007/978-3-031-44626-9_39
Mitral Regurgitation in Heart Failure
Pagnesi, M. (2024) · doi:10.33612/diss.902621665
Where are the Benefits of Treating Acute HF in Light of Evidence-Based Medicine?
Montenegro, C. E. L., Bonatto, M. G., Vieira, J. L., Marcondes‐Braga, F. G., & Moura, L. Z. (2023) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20230085
Pankova, O., & Korzh, O. (2024) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-024-01035-x
Clinical Implications of Ventricular-Arterial Coupling and the Role of Therapeutic Interventions
Ikonomidis, I., Pavlidis, G., & Vlastos, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00005-2
New Pharmacotherapeutic Classes for the Management of Heart Failure: A Narrative Review
Haryani, A., & Sangwan, A. (2024) · Cureus · doi:10.7759/cureus.57180
Abordaje inicial del edema agudo de pulmón
Domingo, M., & Lledó, E. C. (2024) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2023.10.007
Intensivtherapie bei akuter Herzinsuffizienz, kardiogenem Schock und Herzbeuteltamponade
Iken, S., Calineata, M., Reyher, C., & Zierer, A. F. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-68699-7_61
McCallum, W. I., & Sarnak, M. J. (2024) · Nephrology Self-Assessment Program · doi:10.58483/nsap.00042024
Sex differences in relaxin responses in adults and with aging
Barsha, G., & Denton, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22266-5.00007-0
Ajay, A., Biju, P., Ajay, H., Tripathi, R., Lip, G. Y. H., & Sankaranarayanan, R. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2438663
Galluzzo, A., & Pöss, J. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf112
Ufnal, M., Quintana‐Hayashi, M. P., Connolly, K., Pettersen, D., Cselényi, Z., Jučaitė, A., Schou, M., Varrone, A., Chan, M., & Lund, L. H. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15412
Use of vasodilators in heart failure
Burch, M., Lava, S. A. G., & Thiruchelvam, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00059-6
Cristodulo, R., Espinoza, F., Vaca, C., Ureña, D., Rejas, I. A., Rojas, J., Giorgi, J. M., Kaplinsky, E., & Barbagelata, A. (2025) · REC CardioClinics · doi:10.1016/j.rccl.2025.09.003
Chen, Y., Voors, A. A., Jaarsma, T., Lang, C. C., Sama, I. E., Akkerhuis, K. M., Boersma, E., Hillege, H. L., & Postmus, D. (2021) · Figshare · doi:10.6084/m9.figshare.13647238
Self-citationChen, Y., Voors, A. A., Jaarsma, T., Lang, C. C., Sama, I. E., Akkerhuis, K. M., Boersma, E., Hillege, H. L., & Postmus, D. (2021) · Figshare · doi:10.6084/m9.figshare.13647235
Self-citationChen, Y., Voors, A. A., Jaarsma, T., Lang, C. C., Sama, I. E., Akkerhuis, K. M., Boersma, E., Hillege, H. L., & Postmus, D. (2021) · Figshare · doi:10.6084/m9.figshare.13647241
Self-citationCleland, J. G. F., Lyon, A., McDonagh, T. A., & McMurray, J. J. V. (2020) · Srce i krvni sudovi · doi:10.5937/siks2002073c
Self-citationGarofalo, M., Panichella, G., & Aimo, A. (2026) · Advances in clinical chemistry · doi:10.1016/bs.acc.2026.03.005
Li, G., Li, F., Huang, M., Wu, B., Song, Z., Yan, J., Liu, F., Li, Z., Zou, Z., & He, Z. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134519
Olesen, A. S. O., Lukoschewitz, J. D., Taraldsen, I. A., Najim, A., Caidi, N. O. E., Haastrup, S. B., Tonning, S. H., Gregersen, R., Nygaard, H. H., Doleman, B., et al. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107461
Cardiorenal Syndrome Type 1 in Patients with Heart Failure with Preserved Ejection Fraction
Savić, L., Lasica, R., Krljanać, G., Stankovic, S. D., Matić, D., Simic, D., Djukanovic, L., & Ašanin, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15114033
Divergent activation of the RXFP1 relaxin receptor by protein and small molecule agonistsPreprint
Osei‐Owusu, J., Girbau, T., Wang, X., Smith, J. S., Shen, P., Erlandson, S. C., Williamson, A. K., Cong, X., Grinstaff, M. W., Kahne, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.10.731386
Massive Pakistani genome study reveals thousands of naturally inactivated genes
Priyadarshini, S. (2026) · Nature India · doi:10.1038/d44151-026-00119-4
Spray-Dried Formulations of Relaxin-H2 for Inhalation
Miller, D. P., Kadrichu, N. P., Tarara, T. E., Kuehl, P. J., Patton, J. S., & Weers, J. G. (2026) · Pharmaceutical Research · doi:10.1007/s11095-026-04156-7
Dyspnea in heart failure: pathophysiology, clinical assessment, and evidence from clinical trials
Garus, M., Guzik, M., Tymków, R., Gajewski, P., Zymliński, R., & Biegus, J. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10659-7
Chronic Kidney Disease-Associated Cardiomyopathy: Mechanisms and Therapeutic Strategies
Grigoriou, K., Lamprou, V., Chatzichidiroglou, A., Theofilis, P., Iliakis, P., Apostolos, A., Ktenopoulos, N., Karagiannidis, E., Antoniadis, A. P., Fragakis, N., et al. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm51534
The role of biomarkers across the care continuum in acute heart failure
Kalaycı, A., Gibson, C. M., & Januzzi, J. L. (2026) · Biomarker Research · doi:10.1186/s40364-026-00987-z
Januzzi, J. L., Rosenmeier, J. B., Pizzato, P. E., Quintana‐Hayashi, M. P., Chan, L.-S. M., Johannesson, P., Bhattacharya, C. S., Aradi, D., Schaap, J., Vesely, J., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.082763
Self-citationTranslational biology of human cardiac fibrosis
Parvathaneni, A., Lavine, K. J., & Priest, J. R. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00891-7
BindingDB (2026) · UC San Diego · doi:10.7270/q22z1bgp
Metadata
- Authors
- Metra, M., Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Pang, P. S., Ponikowski, P., Voors, A. A., Adams, K. F., Anker, S. D., Arias-Mendoza, A., Avendaño, P., Bacal, F., Böhm, M., Bortman, G., Cleland, J. G. F., Cohen-Solal, A., Crespo-Leiro, M. G., Dorobantu, M., Echeverría, L. E., Ferrari, R., Goland, S., Goncalvesová, E., Goudev, A., Køber, L., Lema-Osores, J., Levy, P. D., McDonald, K., Manga, P., Merkely, B., Mueller, C., Pieske, B., Silva-Cardoso, J., Špinar, J., Squire, I., Stępińska, J., Van Mieghem, W., von Lewinski, D., Wikström, G., Yilmaz, M. B., Hagner, N., Holbro, T., Hua, T. A., Sabarwal, S. V., Severin, T., Szecsödy, P., & Gimpelewicz, C.
- Affiliations
- San Francisco VA Medical Center (US)
- University of North Carolina at Chapel Hill (US)
- From Cardiology, Department of Medical and Surgical Specialties, Radiologic Sciences, and Public Health, University of Brescia, Brescia (M.M.), Centro Cardiologico Universitario di Ferrara, University of Ferrara, Ferrara (R.F.), and Maria Cecilia Hospital, GVM Care and Research, Cotignola (R.F.) — all in Italy; the Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, San Francisco (J.R.T.), and the Division of...
- University of Copenhagen (DK)
- University College Dublin (IE)
- Semmelweis University (HU)
- Uppsala University (SE)
- ORCID
- Metra, Marco
- Teerlink, John R.
- Cotter, Gad
- Davison, Beth A.
- Felker, G. Michael
- Filippatos, Gerasimos
- Greenberg, Barry H.
- Pang, Peter S.
- Ponikowski, Piotr
- Voors, Adriaan A.
- Anker, Stefan D.
- Bacal, Fernando
- Böhm, Michael
- Bortman, Guillermo
- Cleland, John G.F.
- Echeverría, Luis E.
- Ferrari, Roberto
- Goland, Sorel
- Goudev, Assen
- Køber, Lars
- Levy, Phillip D.
- McDonald, Kenneth
- Manga, Pravin
- Merkely, Béla
- Mueller, Christian
- Pieske, Burkert
- Špinar, Jindřich
- Squire, Iain
- Stępińska, Janina
- Wikström, Gerhard
- Gimpelewicz, Claudio
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-08-22
- Volume
- 381
- Issue
- 8
- Pages
- 716-726
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2969766757
- Cited by
- 282
- References
- 32
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 45 · 2023: 42 · 2022: 41 · 2021: 47 · 2020: 38 · 2019: 13
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- HAL (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
- Funders
- Novartis Pharma AG
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy-related medical research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- serelaxin, relaxin-2, acute heart failure, cardiovascular mortality, worsening heart failure, vasodilator therapy, natriuretic peptides, renal failure, dyspnea, hospital readmission, adverse events, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction, length of hospital stay
- MeSH terms
- Acute Disease, Aged, Blood Pressure, Cardiovascular Diseases, Double-Blind Method, Female, Heart Failure, Hospitalization, Humans, Infusions, Intravenous, Male, Recombinant Proteins, Relaxin, Vasodilator Agents, Incidence, Treatment Failure, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
